Explore the Agenda
8:00 am Check-in, Coffee & Light Breakfast
Workshop A
9:00 am Looking Beyond Eosinophils to Novel Biomarkers Guiding Patient Selection, Monitoring Therapeutic Response & Driving Efficacy Progression in Chronic Obstructive Pulmonary Disease
This interactive workshop will focus on the critical role of biomarkers in shaping the future of COPD treatment. Participants will learn how emerging biomarkers can inform patient selection, monitor therapeutic response, and de-risk early-phase programs. The session will highlight strategies for multi-omics integration, linking biomarkers with imaging and clinical data, and translating molecular insights into actionable approaches for more precise COPD management.
Workshop Highlights
- Understand current biomarker gaps and why validated predictive and pharmacodynamic markers are urgently needed beyond blood eosinophils to guide therapy development
- Explore multi-omics strategies to identify disease-driving pathways and molecular endotypes, enabling more precise patient stratification and tailored interventions
- Learn how biomarkers can inform early decisions, optimizing patient selection, trial design, and monitoring of treatment response
- Evaluate integrated approaches that combine biomarker, imaging, and clinical data to strengthen translational insights and improve therapeutic targeting
- Gain insight into clinical and regulatory considerations, including challenges in developing biomarkers that are both actionable and meaningful for guiding treatment strategies
12:00 pm Lunch Break & Networking
Workshop B
1:00 pm Unlocking the Power of Advanced Imaging Technologies from MRI to MicroCT & Evolving AI & ML to Drug Development From POC to Target Engagement, Diagnosis, & Disease Progression in COPD
This hands-on workshop will explore how advanced imaging technologies combined with artificial intelligence are revolutionizing respiratory research. Attendees will gain practical insights into leveraging high-resolution imaging, machine learning, and novel diagnostic tools to better understand disease progression, identify patient subtypes, and accelerate drug development. The session will focus on actionable strategies to integrate imaging and AI into translational research and early-phase clinical programs.
Workshop Highlights
- Explore cutting-edge imaging technologies to assess structural and functional lung changes, providing more precise measures of disease progression and treatment response including how imaging modalities can compliment each other
- Learn how AI enhances imaging interpretation, enabling rapid, reproducible analysis of complex datasets and uncovering novel biomarkers previously inaccessible through manual review
- Understand practical applications for early detection, including oscillometry and imaging-derived endpoints, to support earlier intervention and improved patient stratification
- Evaluate integration of imaging with molecular and clinical data, enabling a holistic view of disease biology and more accurate identification of patient subtypes
- Gain insights into translational and drug development potential, including how AI-driven imaging can accelerate early proof-of-concept studies and inform next-generation endpoints, while recognizing technical and regulatory considerations